Phenotypic and genotypic characterization of

Samuel O Ajoseh, Abdul-Azeez A Anjorin, Hanka Brangsch, Heinrich Neubauer, Gamal Wareth, Kabiru O Akinyemi

Abstract read

In one paragraph

Article in One health (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

In silico metabolic profiling of non-baumannii Acinetobacter species uncovers conserved functions and provides first evidence of siderophore biosynthetic genes in Acinetobacter junii.Scientific reports · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Samuel O AjosehDepartment of Microbiology, Faculty of Science, Lagos State University, P.M.B 0001, Ojo, Lagos, Nigeria.

Abdul-Azeez A AnjorinDepartment of Microbiology, Faculty of Science, Lagos State University, P.M.B 0001, Ojo, Lagos, Nigeria.

Hanka BrangschInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institut (FLI), 07743 Jena, Germany.

Heinrich NeubauerInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institut (FLI), 07743 Jena, Germany.

Gamal WarethInstitute of Bacterial Infections and Zoonoses, Friedrich-Loeffler-Institut (FLI), 07743 Jena, Germany.

Kabiru O AkinyemiDepartment of Microbiology, Faculty of Science, Lagos State University, P.M.B 0001, Ojo, Lagos, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The emerging threat of multidrug-resistant (MDR) Aim: This investigation characterized the microbial traits and genetic variation of Methods: From April 2023 to March 2024, 2835 samples were collected (1410 human, 1020 animal, and 405 environmental), processed, and the isolates were identified by classical microbiological methods. Further identification was carried out by Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) mass spectrometry and confirmed by Whole Genome Sequencing (WGS). Antibiotic susceptibility testing (AST) was assessed by the microdilution method using the MICRONAUT system. WGS data were utilized for analyzing virulence factors, antimicrobial resistance (AMR) determinants, and phylogenetic lineages. Results: Nineteen isolates were confirmed as Conclusion: This study revealed the existence of

Indexed as

AcinetobacterAntimicrobial resistanceOne healthPhylogenomicVirulence factorsWhole genome sequencing

Identifiers

PMID41890979

DOI10.1016/j.onehlt.2026.101388

PMCPMC13015215

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.